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Objective: Consistent long-term follow-up data of thoracic endovascular repair (TEVAR) for acute blunt thoracic aortic
injury (BTAI) are largely absent at this time. The late outcomes of TEVAR for BTAI are the focus of this study to
evaluate the durability of this type of repair.
Methods: The records of 46 consecutive cases of TEVAR for BTAI from November 2000 to August 2012 were reviewed.
Patient demographics, lesion characteristics, procedure details, and outcomes were recorded. We performed a clinical and
body computed tomography angiography follow-up at 1, 6, and 12 months after the intervention; thereafter, it was done
on a yearly basis if device-related defects were ruled out.
Results: There were 35 (76.1%) males. Mean age was 39 6 18 years (range, 17-92). Indications for intervention were
BTAI at the aortic isthmus in 73.9% (n[ 34) of the cases, and in the proximal one-half of the descending thoracic aorta
in the remaining 26.1% (n [ 12). Pseudoaneurysm or free rupture accounted for 44 (95.6%) cases. Primary technical
success was obtained in all cases. All patients survived the intervention, open conversion was never required, and no
patient required reintervention. In-hospital mortality was 6.5% (n [ 3). Mean follow-up was 66 6 46 months (range,
1-144; median, 72). No patient was lost during this period. All patients who were discharged from the hospital are still
alive. Aortic hematoma or hemothorax were completely reabsorbed in 42 (97.7%) cases. Endoleak or modiﬁcations of the
native aorta were never detected; endograft-related complication was observed in one (2.3%) case only. An asymptomatic
collapse was observed at a 36-month follow-up and was managed conservatively.
Conclusions: Midterm follow-up of TEVAR for acute BTAI is feasible with satisfactory late outcomes. In our experience,
TEVAR is a durable and deﬁnitive treatment for BTAI. (J Vasc Surg 2013;58:1483-9.)Multiple studies and meta-analyses have ascertained
the favorable early outcomes with thoracic endovascular
repair (TEVAR) if compared with the traditional open
surgical approach for acute blunt thoracic aortic injury
(BTAI).1-6 On the other hand, it has been hypothesized
that in the long run, TEVAR may be burdened by some
critical issues. Progressive expansion with aging in other-
wise healthy aortas, device-related complications, and reit-
erated radiation exposure are all aspects that are still under
investigation.7-9 On the basis of these considerations,
TEVAR for BTAI has to be yet conﬁrmed as deﬁnitive
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ported results in the early follow-up while emphasizing
the importance of long-term outcomes that have been
affected negatively by the poor rate of adherence to the
radiologic follow-up.10-17 The aim of this study was to
review the late outcomes of TEVAR in patients presenting
with acute BTAI.
METHODS
Patient population. Between November 2000 and
August 2012, all patients undergoing TEVAR for BTAI
were identiﬁed and included into the analysis. This is
a retrospective multicenter study; all clinical and procedural
data were prospectively collected and recorded into a dedi-
cated computerized database. This database contains 62
patient-speciﬁc and procedure-speciﬁc variables. Informa-
tion about demographics, comorbidities, medical and
surgical history, operative details, and postoperative events
during the hospital stay were all registered.
Deﬁnition. All patients underwent preoperative total
body computed tomography angiography (CTA) to iden-
tify concomitant vascular, cerebral, or thoracoabdominal
visceral injuries. Intervention was performed in the theatre,
equipped to perform either conventional or endovascular
procedures. General anesthesia was routinely performed.
Short-term antibiotic prophylaxis was administered
(cefazoline 2 g bid or vancomicyn 1 g bid); the intravenous
heparinization at a dose of 40-50 units/kg was used
after having excluded cerebral or visceral hemorrhage;1483
Table I. Patient characteristics and comorbidities
Demographic data
M:F 35:11
Mean age 39 6 18
Medical history
Hypertension 12 (26.1)
Obesity (BMI >30) 6 (13.0)
Dyslipdemia 4 (8.7)
COPD 4 (8.7)
Ischemic heart/valve disease 3 (6.5)
Diabetes 2 (4.3)
CVA 1 (2.2)
BMI, Body mass index; COPD, chronic obstructive pulmonary disease;
CVA, history of cerebrovascular accident.
Continuous data are presented as mean 6 standard deviation and categoric
data as number (%).
Table II. Injury characteristics
Lesion characteristics
Isthmic location 34 (73.9)
“Bovine” conﬁguration 4 (8.7)
Intimal tear 2 (4.4)
Intramural hematoma 0 (0)
Pseudoaneurysm 26 (56.5)
Free rupture 18 (39.1)
Sizing
Diameter, mm 37 6 27
Extent, mm 44 6 16
Distance from CT, mm 18 6 2
Neck angle >60 31 (67.4)
“LZ 2” 17 (36.9)
CT, Celiac trunk; LZ, landing zone.
Continuous data are presented as mean 6 standard deviation and categoric
data as number (%).
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tion (10 UI/mL) to prevent clot formation. The most
suitable common femoral artery was surgically exposed and
used as access vessel for endograft deployment. An iliac
conduit with a standard Dacron (Intergard; Maquet,
Rastatt-Germany) or ringed expanded polytetraﬂuoro-
ethylene (Vascular graft or Propaten; W. L. Gore and
Associates, Flagstaff, Ariz) graft was used if the femoral
vessels were unsuitable. The transaortic route with a direct
puncture of the infrarenal aorta was used when laparotomy
was performed to repair concomitant intra-abdominal
injuries. Endograft oversizing was maintained in the 10%-
20% range, and proximal attachment site was not routinely
ballooned except for selected cases. The left subclavian
artery was intentionally covered if required. Upon awak-
ening, patients were neurologically evaluated to identify
any sign of stroke and/or vertebro-basilar insufﬁciency.
Clinical evaluation as well as echo-color-Doppler scan of
the left arm was performed in all patients immediately after
the procedure or in the following days to detect any
potential relevant sign of upper arm ischemia.
Three different thoracic devices were implanted:
Excluder/TAG/C-TAG (W. L. Gore and Associates),
Talent/Valiant/Captivia (Medtronic Vascular, Santa
Rosa, Calif), and TX-1/TX-2 (Cook, Bloomington, Ind).
Abdominal endograft cuffs were never used.
Deﬁnition and follow-up. Anatomic and operative
risks were calculated accordingly to risk scores.18,19
Aortic injuries were classiﬁed into four grades according
to the classiﬁcation proposed by Azizzadeh et al.14 Prox-
imal landing zone of the thoracic endograft was deﬁned
following the “arch map” classiﬁcation.20 A “bovine-type”
arch conﬁguration was deﬁned for variants of left common
carotid artery.21 We performed a clinical and CTA follow-
up at 1, 6, and 12 months after the intervention; thereafter,
it was done on an yearly basis if device-related defects were
ruled out. We paid careful attention to thoracic aortic
diameters measurement at the edges of the endograft to
evaluate any aortic modiﬁcations; the largest outer wall to
outer wall diameter was recorded at these levels.
Data analysis. Statistical analysis was computed using
SPSS, release 16.0 for Windows (SPSS Inc, Chicago, Ill).
Continuous variables were compared between groups
with unpaired Student t-test for normally distributed
values; otherwise, the Mann-Whitney U test was used. In
case of dichotomous variables, group differences were
examined by Pearson c2 or Fisher exact tests as appropriate.
Results are expressed as mean 6 standard deviation for
continuous variables and frequencies for the categorical
ones. All tests were two-sided with the alpha level set at
.05 for statistical signiﬁcance.
RESULTS
Population. We treated 46 patients; there were 35
(76.1%) males. Mean age was 39 6 18 years (range, 17-
92). Demographics and medical history are shown in
Table I. Aortic injury was located at the aortic isthmus in
73.9% (n ¼ 34) of the cases and in the proximal one-thirdof the descending thoracic aorta in 26.1% (n ¼ 12). No
ascending or transverse arch injuries were observed. Pseu-
doaneurysm or free rupture accounted for 44 (95.6%)
cases; grade I injury was treated in two (4.4%) cases only.
All BTAI characteristics are reported in Table II. Table III
reports the operative risk factors.
An urgent intervention was required in 30 (65.2%)
cases. The femoral artery was the access vessel in 43
(93.5%) patients; an iliac conduit was performed in
two (4.4%) cases whereas a direct transaortic route was
used in one (2.2%). All but two BTAIs were treated with
a single endograft; mean aortic coverage was 12 6 2 cm
(range, 7-20). The left subclavian artery was partially or
completely covered in 20 (43.5%) patients and was prophy-
lactically revascularized in one (2.2%) case only. Operative
details are reported in Table IV.
Early outcomes. No patient died from aortic rupture
while awaiting repair. Primary technical success was ob-
tained in all cases; all patients survived the intervention.
Open conversion was never required. Thirty-nine (84.8%)
patients were admitted in the intensive care unit; mean
intensive care unit stay was 18 6 21 days (range, 1-61;
median 13). In-hospital mortality was 6.5% (n ¼ 3). The
cause of death was aortic-related in all patients; it
was a consequence of the profound hemorrhagic shock
Table III. Operative risks of the patients
Operative risk
Hemorrhagic shock 23 (50.0)
Urgent intervention 30 (65.2)
GCS 9.8 6 5.7
ISS 36.9 6 27.4
EuroSCORE 8.1 6 3.1
Associated lesions
Bones 32 (69.6)
Lung 26 (56.5)
Visceral 18 (39.1)
Cerebral 9 (19.6)
Vascular 5 (10.8)
Multiple 32 (69.6)
EuroSCORE, European System for Cardiac Operative Risk Evaluation;
GCS, Glasgow Coma Score; ISS, Injury Severity Score; SD, standard
deviation.
Continuous data are presented as mean 6 standard deviation and categoric
data as number (%).
Table IV. Operative details and technical aspects
Operative details
Prox free-ﬂo 25 (54.3)
EG diameter, mm 29 6 4
Aortic coverage, mm 12 6 2
Duration of intervention, minutes 76 6 33
Blood loss, mL 664 6 1118
Contrast agent, mL 72 6 27
LSA coverage 20 (43.5)
LSA revascularization 1 (2.2)
EG implanted
Thoracic EG 46 (100)
Single EG 44 (95.6)
Site of access
Aorta 1 (2.2)
Iliac artery/conduit 2 (4.4)
Femoral 43 (93.5)
Adjunctive surgical procedures
Lung drainage 13 (28.3)
Bones surgery 12 (26.1)
Visceral lesions repaired 11 (23.9)
Vascular lesions repaired 5 (10.8)
Brain surgery 3 (6.5)
Tracheostomy 2 (4.4)
EG, Endograft; LSA, left subclavian artery; SD, standard deviation.
Continuous data are presented as mean 6 standard deviation and categoric
data as number (%).
Table V. Comparison of the risk proﬁle: univariate
analysis
Survived
(n ¼ 43)
Dead
(n ¼ 3)
P
value
Risk proﬁle
Mean age 37 6 18 55 6 16 .099
Free rupture 15 (34.8) 3 (100.0) .053
Hemorrhagic shock 20 (46.5) 3 (100.0) .233
GCS 9.9 6 5.7 9.5 6 7.8 .908
ISS 34.4 6 28.4 54.5 6 6.4 .232
EuroSCORE 7.8 6 3.1 10 6 2.8 .239
Associated visceral lesions 15 (34.8) 3 (100.0) .053
Adjunctive surgical
procedures
27 (69.6) 3 (100.0) .541
Duration of intervention,
minutes
80.3 6 33.3 47.5 6 3.5 .098
Blood loss, mL 352 6 716 2850 6 919 <.001
Transfusion, units 4.5 6 4.8 16 6 15 .001
EuroSCORE, European System for Cardiac Operative Risk Evaluation;
GCS, Glasgow Coma Score; ISS, Injury Severity Score; SD, standard
deviation.
Continuous data are presented as mean 6 standard deviation and categoric
data as number (%).
Table VI. Late clinical and procedure-related results
Late outcomes
Follow-up, months 66 6 46
<1 year 8 (18.6)
1-3 years 7 (16.3)
3-5 years 15 (34.9)
>5 years 13 (30.2)
Survival 43 (100)
EG complication 1 (2.3)
Aortic modiﬁcation 0 (0)
Lesion reabsorption 42 (97.7)
EG, Endograft; SD, standard deviation.
Continuous data are presented as mean 6 standard deviation and categoric
data as number (%).
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American Association for Vascular Surgery (SVS/AAVS)
complication rate was 1.2 6 1.3 (range, 0-3); spinal cord
ischemia, cerebrovascular events, or arm ischemia were not
observed. Median hospitalization was 8 days (range, 2-83).
There were no reinterventions.
Late outcomes. Mean follow-up was 66 6 46 months
(range, 1-144; median, 72). No patient was lost during this
period. Overall, 13 (30.2%) patients had a 5-year follow-up
period completed (Table VI). All patients who were dis-
charged from the hospital are still alive. Aortic hematoma
or hemothorax were completely reabsorbed in 42 (97.7%)
cases. Endograft-related complication was observed in one
(2.3%) case only; a collapse was observed at a 36-month
follow-up (Fig). At that time, a 20-year-old patient wasclinically asymptomatic; either aortic or peripheral blood
ﬂow was not impaired and no signs of pseudocoarctation
was noted. We did not observe further endograft (EG)-
related complication, speciﬁcally endoleaks, infection,
breakage, or partial or complete thrombosis as reported in
the few papers that reported long-term follow-up
(Table VII). Interestingly, modiﬁcations of the native
aorta, meaning stenosis, or increase in size at the edges of
the EG, were never detected.
DISCUSSION
The most important aspect of our study is the length of
follow-up, with full adherence of patients to the radiologic
follow-up. Another important aspect is the absence of
signiﬁcant morphologic changes of the native aorta that
could have been determined by the mechanical forces of
the EG on an otherwise healthy aorta.
The recent guidelines of the SVS/AAVS recognized
that TEVAR for BTAI is associated with improved
outcomes compared with open repair, especially in the
Fig. A and B, Follow-up computed tomography (CT) of an endograft infolding. A1, Shows the good apposition
(arrows) to the aortic arch curvature of the endograft and the detection of the infolding (A2) at the distal edge (arrows)
of the endograft, 36 months after the procedure. B, Follow-up CT several years (dotted arrows) after this event: the
morphology of the endograft (B1, arrow) is stable and the peripheral circulation (B2) is not impaired.
Table VII. Summary of the data from single-center experiences (at least 15 cases and >12 months follow-up)
Author Year (period) Cases, No. Follow-up, months Lost, % Reintervention, % Complication (device-related)
Marcheix et al30 1996-2005 33 32.4 5.1 0 Thrombosis (1)
Fracture (1)
Orend et al15 1999-2006 34 43.8 NS 11.7 None
Canaud et al14 2001-2007 27 40 0 4 Collapse (1)
Urgnani et al25 1997-2007 20 58 NS 0 Fracture (2)
Neschis et al31 2004-2008 43 7.4 2.3 6.9 Endoleak (4)
Collapse (2)
Azizzadeh et al13 2005-2008 27 15 44 0 None
Garcia-Toca et al16 2001-2008 24 21 NS 0 None
Fernandez et al10 1999-2008 20 43.5 NS 10 Fracture (1)
Collapse (1)
Thrombosis (1)
Patel et al22 2002-2010 19 36.4 0 5.2 Collapse (1)
Irace et al32 2001-2011 16 5, >5 years NS 0 Fracture (2)
Riesenman et al24 1990-2010 26 15.8 23 19 Bird beak (2)
Lioupis et al11 2002-2011 24 NS 16.6 4.1 Pseudocoarctation (1)
Marone et al27 2003-2010 28 37.3 7.7 4.2 Thrombosis (1)
Present 2000-2012 46 66.2 0 0 Collapse (1)
NS, Not speciﬁed.
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of the treatment.6 On the other hand, two levels of concern
still burden the long-term follow-up of TEVAR. The ﬁrst is
the few reports that reported late outcomes, and the
second is the poor adherence of the patients to the
follow-up.7-9,22-24 Only four papers of TEVAR for BTAI
reported a follow-up exceeding 40 months10,14,15,25; the
longest mean duration has been published by Urgnaniet al25 with a mean of 4.8 years. Unfortunately, three of
these four papers did not specify the patients’ participation
to the visits and CTA follow-up.10,15,25 The value of our
study is twofold: the length of follow-up and the rigorous
and complete adherence to the clinical visit and CTA.
These two data are very important, especially in light of
the fact that most of the authors found them very difﬁcult
to complete, having only 30%-65% follow-up because most
JOURNAL OF VASCULAR SURGERY
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explain the completeness of our follow-up may be that
none of the patients came from a catchment area far
away from our centers. This logistic aspect and the recruit-
ment capacity of the centers involved in this study may
have been the two determinants to obtain this result.
Conventional open repair is still considered the gold
standard in the long run thanks to the durable results
and the low rate of reintervention. However, a long-term
comparison between TEVAR and open repair evaluating
clinical outcomes or for EG performance is still absent.
Patel et al22 reported that the risk of treatment failure
was signiﬁcantly higher in TEVAR group but this was
determined by one reintervention only, which occurred
within the ﬁrst year of treatment. Therefore, it was not
a long-term complication of TEVAR. The 5.8% reinter-
vention rate after TEVAR estimated in the series with
a follow-up longer than 3 years is higher than the reinter-
vention rate for conventional repair, but it is still better
than the late complication rate of TEVAR for non-
traumatic pathology.10,14,15,22,25-27 We should also empha-
size that an endovascular reintervention was performed in
the vast majority of these cases with excellent results and
no negative impact on mortality.22 Our results are encour-
aging enough; the absence of late complications and need
for reinterventions could contribute to further improve
those results. We have not a ﬁnal explanation for this low
complication rate; potentially, it could have been the avail-
ability of a wide EG inventory that allowed us to treat virtu-
ally all of the native aortic diameters. We are now aware
that the descending aortic diameters in trauma victims
are inﬂuenced by shock, but it is equally true that the resus-
citation protocol in all these cases probably balanced the
measurements and, therefore, the choice of a more appro-
priate sizing of the EG.28 We could have treated aortic
lesions in a “more favorable” location at the isthmus.
Although more than 60% of the patients had a challenging
arch angle of at least 60, only one-third of them required
coverage in landing zone 2, exploiting the straighter
portion of the arch to be used as proximal landing zone.
Long-term results are very important, particularly in
trauma victims who are more often young. The morpho-
logic changes of the aorta that come with age may still
occur in the late phases and may lead to EG-related compli-
cations.7-9 We acknowledge that morphologic changes
because of aortic growth would be seen in an even longer
period compared with our current follow-up; however, we
did not observe any aortic modiﬁcations in the midterm.
Although not all patients passed the 5-year follow-up, the
mean length of those who have passed this target has
been extended well beyond the same at 88.5 months.29
In light of these late results and in consideration of those
signiﬁcantly better in the early postoperative period, it
would not be totally misleading to think of TEVAR as
effective and durable.
One of the most reported complications following
TEVAR for BTAI is EG collapse or malapposition.8,9 Our
experience is not different from the literature data becausethe only complication that we detected in the follow-up
was an EG collapse. This case can be useful for some talking
points. First, considering the cause of the collapse, we recog-
nized that the mismatch between the EG and aortic diam-
eter and the tight aortic curvature radius were the two
triggers of this worrisome complication. Our ﬁnding is
conﬁrmed by previous studies, which identiﬁed this
phenomenon to be primarily due to excessive device over-
sizing associated with the extreme angle of the aortic
arch.8,9 Second, we were surprised that the patient was clin-
ically asymptomatic. However, it should be remembered
that in the same review of Jonker et al8 most of the patients
did not have symptoms. Finally, while typically noted within
the early postoperative period, this abnormality was also
detected later in the follow-up as occurred in our case.
The available data and the late ﬁndings of our experience
emphasize the need of a rigorous follow-up. First and fore-
most, it is to conﬁrm the success of TEVAR, but most
importantly, to detect any type of EG-related complications
to conﬁrm its actual durability in the long run.
The recent SVS clinical guidelines recommend expec-
tant management and serial imaging for patients with
grade 1 or minimal aortic injuries.6 This is the consequence
of the growing knowledge that patients who survived the
ﬁrst few hours in the hospital may be a self-selected subset
who have a more stable injury and are unlikely to rupture
later.9,23 Despite this ﬁnding and the fact that this subset
has the less frequent BTAIs, we gave the utmost attention
to this type of injury. Riesenman et al24 opted for a nonop-
erative medical management in three cases of grade 1
injury. They operated on one of them (33%) within the
ﬁrst 6 months of the follow-up because of a pseudoaneur-
ysm development. Marone et al27 had four delayed repair
for stable injuries, but all BTAIs were treated within the
indexed admission since their patients presented at least
one criterion of instability and imaging ﬁndings of impend-
ing rupture. We had similar ﬁndings and opted for an
aggressive approach: two cases of grade 1 injury were
treated preventively because of uncertainty regarding
progression of the injury based on long intimal tears or
aortic circumferential lesion in patients complaining of per-
sisting thoracic pain. This approach may be criticized by
some. This subset may be unnecessarily treated and unjus-
tiﬁably exposed to device-related risks; however, as previ-
ously documented, the EG-related complication rate was
lower than those reported.
This study has some limitations: it is retrospective,
although the data were prospectively collected, and it is
also statistically limited because of the small number of
patients enrolled. In addition, comparative analyses with
conventional surgery or expectant management have not
yet been performed. Despite these shortcomings, a similar
design is present in other published studies and results are
in agreement with them.
CONCLUSIONS
In our experience, TEVAR of acute BTAIs has satis-
fying results in the midterm follow-up and shows that the
JOURNAL OF VASCULAR SURGERY
1488 Piffaretti et al December 2013total adherence to the follow-up is feasible. Although in
our experience, long-term results have not yet been
completely available for TEVAR, it is equally true that
late complication rate is low, and concerns are not
conﬁrmed at least in the medium term and may have
been exaggerated by the lack of medical surveillance.
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